Summary & Overview
HCPCS G8968: Documentation of Reason for Not Prescribing Anticoagulant
HCPCS Level II code G8968 captures documentation of the medical reason(s) for not prescribing an FDA‑approved anticoagulant for patients with atrial fibrillation or atrial flutter. The code formalizes recording clinical rationales such as planned or completed atrial appendage occlusion/ligation or enrollment in a relevant clinical trial. Nationally, standardized capture of these reasons supports care coordination, quality measurement, and appropriate claims adjudication where anticoagulation is typically expected but not given.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical scenarios that prompt use of G8968, typical service settings, and how documentation aligns with procedural planning or trial participation. The publication provides benchmarks and policy-relevant notes where available, clarifies coding intent, and summarizes operational considerations for billing teams and clinical documentation staff.
This resource is written for a national audience and is intended to help billing, compliance, and clinical teams understand when G8968 applies, what it documents, and the broader clinical context surrounding nonprescription of anticoagulants in atrial arrhythmia care. Data not available in the input is noted where relevant.
Billing Code Overview
HCPCS Level II code G8968 documents the medical reason(s) for not prescribing an FDA-approved anticoagulant for a patient with atrial fibrillation or atrial flutter. Examples include a planned or present atrial appendage occlusion or ligation, or patient enrollment in a clinical trial related to atrial fibrillation/atrial flutter treatment.
-
Service type: Clinical documentation of anticoagulation contraindication or alternative management plan
-
Typical site of service: Outpatient clinic, cardiology specialty clinic, hospital outpatient department, or other ambulatory care settings where anticoagulation decisions and procedural planning occur
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with non-valvular atrial fibrillation or atrial flutter who would normally be considered for anticoagulation to reduce stroke risk but for whom a prescriber documents a medical reason for not prescribing an FDA‑approved oral anticoagulant. Example: a 78‑year‑old patient with symptomatic persistent atrial fibrillation and a prior major gastrointestinal hemorrhage who is being evaluated for percutaneous left atrial appendage occlusion (LAAO). The cardiology team documents the plan for LAAO and defers systemic anticoagulation pending the procedure and post‑procedural management. Clinical workflow: the electrophysiologist or cardiologist evaluates stroke and bleeding risk, reviews prior bleeding events and comorbidities, discusses LAAO or surgical ligation as an alternative, documents informed consent and the expected timeline, and records the specific medical reason(s) for withholding an FDA‑approved anticoagulant in the medical record to support billing of G8968. Documentation typically appears in the cardiology clinic note, procedural consent, or multidisciplinary conference note, and may reference concurrent enrollment in an atrial fibrillation clinical trial, planned appendage occlusion/ligation, or permanent contraindication to anticoagulation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for documentation or coordination related to the medical rationale for not prescribing anticoagulation. |